Nevertheless, we showed that the plasma CAIX detected in patients with NSCLC is much lower than CAIX concentrations described in renal cell carcinoma, because the very high constitutive HIF-1α levels in these latter tumours and also differences in CAIX expression depending on the cell type (Li et al, 2008). The gene discussed is CA9; the disease is renal cell carcinoma.